Cochrane Abstracts
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for Adults With Newly Diagnosed Multiple Myeloma Ineligible for Transplant." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant. Accessed 10 September 2024.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant. Accessed September 10, 2024.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant
Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for Adults With Newly Diagnosed Multiple Myeloma Ineligible for Transplant [Internet]. In: Cochrane Abstracts. [cited 2024 September 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant
ID - 436447
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant
DB - Evidence Central
DP - Unbound Medicine
ER -
